1. Home
  2. ATKR vs HCM Comparison

ATKR vs HCM Comparison

Compare ATKR & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atkore Inc.

ATKR

Atkore Inc.

HOLD

Current Price

$83.05

Market Cap

2.5B

Sector

Miscellaneous

ML Signal

HOLD

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

HOLD

Current Price

$12.01

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATKR
HCM
Founded
1959
2000
Country
United States
Hong Kong
Employees
N/A
1796
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
ATKR
HCM
Price
$83.05
$12.01
Analyst Decision
Buy
Sell
Analyst Count
4
1
Target Price
$75.67
$13.75
AVG Volume (30 Days)
439.6K
27.8K
Earning Date
05-05-2026
03-05-2026
Dividend Yield
1.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,850,378,000.00
N/A
Revenue This Year
$6.55
$20.60
Revenue Next Year
$3.89
$15.62
P/E Ratio
N/A
$5.49
Revenue Growth
N/A
N/A
52 Week Low
$53.49
$11.72
52 Week High
$80.06
$19.50

Technical Indicators

Market Signals
Indicator
ATKR
HCM
Relative Strength Index (RSI) 69.73 26.82
Support Level $62.26 N/A
Resistance Level N/A $15.75
Average True Range (ATR) 3.17 0.32
MACD 0.12 -0.06
Stochastic Oscillator 97.06 16.67

Price Performance

Historical Comparison
ATKR
HCM

About ATKR Atkore Inc.

Atkore Inc is a manufacturer of Electrical products for the non-residential construction and renovation markets, as well as residential markets, and Safety & Infrastructure products for the construction and industrial markets. The Electrical segment manufactures products used in the construction of electrical power systems including conduit, cable, and installation accessories. This segment serves contractors in partnership with the electrical wholesale channel. The Safety & Infrastructure segment designs and manufactures solutions including metal framing, mechanical pipe, perimeter security, and cable management. These solutions are marketed to contractors, original equipment manufacturers (OEMs), and end-users. The majority of revenue is generated from the Electrical segment.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: